Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 221.50
Bid: 219.00
Ask: 220.00
Change: -0.50 (-0.23%)
Spread: 1.00 (0.457%)
Open: 220.50
High: 221.50
Low: 218.00
Prev. Close: 222.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Ebiquity appoints ITV executive Izlan to board

Mon, 26th Apr 2021 16:02

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Ebiquity PLC - marketing and media consultancy - Appoints Lara Izlan as non-executive director with effect on June 1. Is currently director of Data Strategy at FTSE-250 listed broadcaster ITV PLC.

----------

Arix Bioscience PLC - firm which invests in biotech companies - Acacia Research Corp, a 19% shareholder in Arix will requisition resolutions for Arix's annual general meeting, nominating the appointment of Peregrine Moncreiffe, Issac Kohlberg and Maureen O'Connell to the company's board. Moncreiffe is chair of North Atlantic Smaller Companies Investment Trust PLC and Kohlberg is chief technology development officer for Harvard University.

----------

PureTech Health PLC - clinical-stage biotherapeutics company - Founded entity Gelesis appoints Jane Wildman to board of directors, as it looks to launch its commercial product Plenity in the US. Most recent executive role was as president of personal care consumer products firm Combe Inc, and Wildman has also spent 25 years at Procter & Gamble Co for 25 years from 1983 to 2009.

----------

All Active Asset Capital Ltd - London-based firm seeking investment opportunities in the technology, software and artificial intelligence space - Intends to appoint Frank Cho and Kassir Kayani as managing directors, roles outside of the company's board. Appointments are subject to formal administrative and regulatory requirements. Cho's most recent role is as global agency lead in Business Planning & Operations for Facebook Inc, while Kayani is chief technology officer at CSL Group, a company in the fire and security sector.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
2 Mar 2021 19:11

TRADING UPDATES: Angus in Balcombe blow; YouGov buys Canada asset

TRADING UPDATES: Angus in Balcombe blow; YouGov buys Canada asset

Read more
25 Feb 2021 17:58

TRADING UPDATES: Yellow Cake And Asiamet Resources Plan Fundraises

TRADING UPDATES: Yellow Cake And Asiamet Resources Plan Fundraises

Read more
10 Feb 2021 14:17

IN BRIEF: PureTech Sells 1 Million Karuna Shares; Closes Vor IPO

IN BRIEF: PureTech Sells 1 Million Karuna Shares; Closes Vor IPO

Read more
10 Feb 2021 09:22

PureTech sells down Karuna stake as Vor closes IPO

(Sharecast News) - Clinical-stage biotherapeutics commercialisation company PureTech Health announced on Wednesday that its founded entity Vor Biopharma has closed its initial public offering at a price of $18 per share.

Read more
8 Feb 2021 15:45

EXECUTIVE CHANGES: Smart Metering Systems CFO To Leave At March-End

EXECUTIVE CHANGES: Smart Metering Systems CFO To Leave At March-End

Read more
5 Feb 2021 14:00

IN BRIEF: PureTech Health Investee Vor Biopharma Prices US IPO

IN BRIEF: PureTech Health Investee Vor Biopharma Prices US IPO

Read more
29 Jan 2021 18:26

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

Read more
18 Jan 2021 11:39

PureTech Health Investee Vor Biopharma Looks Set To List On Nasdaq

PureTech Health Investee Vor Biopharma Looks Set To List On Nasdaq

Read more
14 Jan 2021 16:07

IN BRIEF: PureTech's Follica Hires Board Members; Vor Gets Approval

IN BRIEF: PureTech's Follica Hires Board Members; Vor Gets Approval

Read more
12 Jan 2021 12:46

PureTech Health Notes USD25 Million Pfizer Investment In Vedanta

PureTech Health Notes USD25 Million Pfizer Investment In Vedanta

Read more
5 Jan 2021 17:55

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

UK EXECUTIVE CHANGE SUMMARY: Saga Insurance CEO Resigns After One Year

Read more
5 Jan 2021 08:26

PureTech appoints George Farmer as new finance chief

(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health announced on Tuesday that George Farmer has been appointed chief financial officer.

Read more
11 Dec 2020 21:47

IN BRIEF: PureTech Starts Phase 2a Trial Of LYT-100 In Lymphedema

IN BRIEF: PureTech Starts Phase 2a Trial Of LYT-100 In Lymphedema

Read more
11 Dec 2020 20:33

IN BRIEF: PureTech Starts Trial Of LYT-200 In Metastatic Solid Tumors

IN BRIEF: PureTech Starts Trial Of LYT-200 In Metastatic Solid Tumors

Read more
3 Dec 2020 17:55

IN BRIEF: PureTech Health Starts Phase Two Trial Of LYT-100

IN BRIEF: PureTech Health Starts Phase Two Trial Of LYT-100

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.